Tag: Diabetes: Management
Position Statement Addresses Optimal Management of Diabetes
Tools available to help health care providers include guided communication styles, clinical screening tools for psychosocial conditions
Health Coaching With Family Support Aids Patient Activation With Diabetes
However, no significant improvements seen for diabetes-specific cardiac risk or glycemic control
‘Teach-Back’ Communication Strategy Aids Diabetes Outcomes
Patients who use teach-back have fewer diabetes-related complications, hospitalizations, health expenditures
CVD Risk Higher in T2DM Even With Optimal Risk Factor Management
Those with T2DM with optimal risk factor control have greater risk for cardiovascular disease events versus those without T2DM
Sitagliptin May Cut Mortality in T2DM Patients With COVID-19
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes
Manufacturer Prices for Insulin Substantially Higher in the U.S.
Manufacturer prices more than eight times higher in the U.S. than in other high-income countries
SGLT2 Inhibitors Linked to Reduced Risk for Serious Renal Events
Data from three countries showed drop in serious renal events with sodium-glucose cotransporter 2 inhibitors
Diabetes Medication Prescribing Increased 2003 to 2016
However, authors say there is little evidence that doctors are tailoring treatment for patients
Metformin May Cut Mortality Risk in Post-Pancreatitis Diabetes
Survival benefit not seen with ever use of metformin for pancreatic cancer-related diabetes
Medtronic Recalls Some Insulin Pumps Over Cybersecurity Concerns
The company and FDA say certain pumps are vulnerable to hacking
